Who
Robin LaChapelle
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, ArriVent BioPharma.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Sep 2024
- Last trade
- 2 Feb 2026
- Last filed
- 4 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Feb 2026filed 4 Feb 2026 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 2 Feb 2026filed 4 Feb 2026 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 11 Jul 2025filed 15 Jul 2025 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,050 at $0.00 | filing |
| 11 Jul 2025filed 15 Jul 2025 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,600 at $0.00 | filing |
| 11 Jul 2025filed 15 Jul 2025 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,503 at $0.00 | filing |
| 11 Jul 2025filed 15 Jul 2025 | AVBP ArriVent BioPharmaBiotechnology | SEC FORM 4 Code M | $4,6742,050 at $2.28 | filing |
| 11 Jul 2025filed 15 Jul 2025 | AVBP ArriVent BioPharmaBiotechnology | SEC FORM 4 Code M | $5,9282,600 at $2.28 | filing |
| 11 Jul 2025filed 15 Jul 2025 | AVBP ArriVent BioPharmaBiotechnology | SEC FORM 4 Code M | $15K6,503 at $2.28 | filing |
| 3 Feb 2025filed 14 Feb 2025 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,471 at $0.00 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,867 at $0.00 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,164 at $0.00 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,364 at $0.00 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,700 at $0.00 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaBiotechnology | SEC FORM 4 Code M | $17K2,700 at $6.24 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaBiotechnology | SEC FORM 4 Code M | $6,5372,867 at $2.28 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaBiotechnology | SEC FORM 4 Code M | $16K7,164 at $2.28 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaBiotechnology | SEC FORM 4 Code M | $5,6342,471 at $2.28 | filing |
| 19 Sep 2024filed 23 Sep 2024 | AVBP ArriVent BioPharmaBiotechnology | SEC FORM 4 Code M | $45K12,364 at $3.65 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.